ARCHIVES

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 18 No. 46 | November 27, 1992

Download PDF Visit The Full Archive

Related Articles

In Brief: Caplan Receives NSB Public Service Award

March 28, 2014

An “insurgency” targets randomized trials, demands access to investigational drugs.

August 5, 2005

Campath Improves PFS In B-Cell CLL In Phase III Trial

January 26, 2007

Synar Bill Provides FDA Regulation Of Tobacco Products

March 4, 1994

Senate Increases NIH Funding for 2013, Rejects President’s $200+ Million Increase for Program Evaluation Activities

June 22, 2012

ACCC/Oncology Economic Meeting to Examine DRGs, FCCs, Quality

August 9, 1985